Skip to main content (Press Enter).
Skip auxiliary navigation (Press Enter).
Terms and Conditions
Skip main navigation (Press Enter).
Peer Group Communities
Work Group Communities
AUCH Medical Directors Peer Group
Back to Library
Use of COVID-19 Vaccines in the United States Interim Clinical Considerations from the CDC
Summary of recent changes (last updated September 2, 2022):
New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group
Recommendations for use of a bivalent Moderna booster dose in people ages 18 years and older
Recommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 12 years and older
Updated guidance for observation periods following COVID-19 vaccination
Updated guidance on COVID-19 vaccination and multisystem inflammatory syndrome (MIS) in children (MIS-C) and in adults (MIS-A)
Tags and Keywords
Related Entries and Links
No Related Resource entered.
Copyright 2019. All rights reserved.
Powered by Higher Logic